Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L I Irons

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Infection and Immunity|September 1, 1982
Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussisL A Ashworth, L I Irons, A B Dowsett
Biochimica Et Biophysica Acta|June 24, 1991
Binding of NAD+ to pertussis toxinM D Lobban, L I Irons, S van Heyningen
Developments in Biological Standardization|January 1, 1985
Protection against intranasal infection of mice with Bordetella pertussisA Robinson, L A Ashworth, A Baskerville, et al.
The Biochemical Journal|March 1, 1991
The secondary structure of protein G', a robust moleculeC R Goward, L I Irons, J P Murphy, et al.
Developments in Biological Standardization|January 1, 1985
The location of surface antigens of Bordetella pertussis by immuno-electron microscopyL A Ashworth, A B Dowsett, L I Irons, et al.
The Biochemical Journal|May 1, 1992
Effects of guanidinium hydrochloride on the structure and immunological properties of Bordetella pertussis fimbriaeA M Pearce, L I Irons, A Robinson, et al.
Lancet (London, England)|January 12, 1991
Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogensE Miller, L A Ashworth, A Robinson, et al.
Biochemistry|May 6, 1997
Crystal structures of ribonuclease A complexes with 5'-diphosphoadenosine 3'-phosphate and 5'-diphosphoadenosine 2'-phosphate at 1.7 A resolutionD D Leonidas, R Shapiro, L I Irons, et al.
Lancet (London, England)|October 15, 1983
Antigens in whooping cough vaccine and antibody levels induced by vaccination of childrenL A Ashworth, A Robinson, L I Irons, et al.
Biochemistry|August 11, 1999
Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitorD D Leonidas, R Shapiro, L I Irons, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Infection and Immunity|September 1, 1982
Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussisL A Ashworth, L I Irons, A B Dowsett
Biochimica Et Biophysica Acta|June 24, 1991
Binding of NAD+ to pertussis toxinM D Lobban, L I Irons, S van Heyningen
Developments in Biological Standardization|January 1, 1985
Protection against intranasal infection of mice with Bordetella pertussisA Robinson, L A Ashworth, A Baskerville, et al.
The Biochemical Journal|March 1, 1991
The secondary structure of protein G', a robust moleculeC R Goward, L I Irons, J P Murphy, et al.
Developments in Biological Standardization|January 1, 1985
The location of surface antigens of Bordetella pertussis by immuno-electron microscopyL A Ashworth, A B Dowsett, L I Irons, et al.
The Biochemical Journal|May 1, 1992
Effects of guanidinium hydrochloride on the structure and immunological properties of Bordetella pertussis fimbriaeA M Pearce, L I Irons, A Robinson, et al.
Lancet (London, England)|January 12, 1991
Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogensE Miller, L A Ashworth, A Robinson, et al.
Biochemistry|May 6, 1997
Crystal structures of ribonuclease A complexes with 5'-diphosphoadenosine 3'-phosphate and 5'-diphosphoadenosine 2'-phosphate at 1.7 A resolutionD D Leonidas, R Shapiro, L I Irons, et al.
Lancet (London, England)|October 15, 1983
Antigens in whooping cough vaccine and antibody levels induced by vaccination of childrenL A Ashworth, A Robinson, L I Irons, et al.
Biochemistry|August 11, 1999
Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitorD D Leonidas, R Shapiro, L I Irons, et al.
Pageof 4